hVIVO plc (AIM: HVO)
London
· Delayed Price · Currency is GBP · Price in GBX 19.16
+0.16 (0.84%)
Jan 22, 2025, 10:51 AM GMT+1
hVIVO Revenue
hVIVO had revenue of 37.19M GBP in the half year ending June 30, 2024, with 97.09% growth. This brings the company's revenue in the last twelve months to 67.21M, up 11.14% year-over-year. In the year 2023, hVIVO had annual revenue of 58.67M with 15.72% growth.
Revenue (ttm)
67.21M
Revenue Growth
+11.14%
P/S Ratio
1.92
Revenue / Employee
245.29K
Employees
274
Market Cap
129.27M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 38.20B |
| GSK plc | 31.31B |
| Haleon | 11.24B |
| Smith & Nephew | 4.46B |
| ConvaTec Group | 1.74B |
| Hikma Pharmaceuticals | 2.39B |
| HUTCHMED (China) | 483.31M |
| Oxford Nanopore Technologies | 167.75M |
hVIVO News
- 4 months ago - Half Year 2024 hVIVO PLC Investor Presentation Transcript - GuruFocus
- 4 months ago - Earnings rise 68pc at pharmaceutical services firm Hvivo - Independent Ireland